Trial site
Byers Eye Institute at Stanford University
- 8running trials
- 4closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Glaucoma6 trials
- Graves' disease2 trials
- Melanoma2 trials
- Phase
- Phase 23 trials
- Phase 12 trials
- Phase 32 trials
- Phase 1/21 trial
- Phase 41 trial
- Status
- Active, not recruiting5 trials
- Completed3 trials
- Recruiting2 trials
- Enrolling by invitation1 trial
- Terminated1 trial
- Lead sponsor
- Stanford University6 trials
- Aura Biosciences2 trials
- Viridian Therapeutics, Inc.2 trials
- NYU Langone Health1 trial
- Quan Dong Nguyen1 trial
Running trials
Enrolling by invitation
Recruiting
Electrical Stimulation for Vision Neuroenhancement in Glaucoma
Active, not recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Dual Intravitreal Implantation of NT-501 Encapsulated Cell Therapy for Glaucoma
Active, not recruiting
A Registry of Subjects With Primary Indeterminate Lesions or Choroidal Melanoma
Active, not recruiting
Study of NT-501 Encapsulated Cell Therapy for Glaucoma Neuroprotection and Vision Restoration
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Glaucoma3 recruiting
Closed trials
Completed
Safety, Tolerability, and Distribution of Laquinimod Eye Drops : The LION Study
Completed
Terminated
Completed
Site data: ClinicalTrials.govUpdated 17 Nov 2026